Connection

DAVID G JOHNSON to Humans

This is a "connection" page, showing publications DAVID G JOHNSON has written about Humans.
Connection Strength

0.819
  1. Herpesvirus Nuclear Egress across the Outer Nuclear Membrane. Viruses. 2021 11 24; 13(12).
    View in: PubMed
    Score: 0.016
  2. Modeling financial outcomes and quantifying risk in episode-based payment models. Am J Manag Care. 2021 08 01; 27(8):e278-e286.
    View in: PubMed
    Score: 0.016
  3. Financial Margins for Prostate Cancer Surgery: Quantifying the Impact of Modifiable Cost Inputs in an Episode Based Reimbursement Model. J Urol. 2019 09; 202(3):539-545.
    View in: PubMed
    Score: 0.014
  4. Focal Therapy Should Not Be Considered for Men with Gleason Grade Group 3-5 Prostate Cancer. Eur Urol Focus. 2020 03 15; 6(2):203-204.
    View in: PubMed
    Score: 0.014
  5. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. Cancer. 2019 09 01; 125(17):2955-2964.
    View in: PubMed
    Score: 0.014
  6. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2019 05; 75(5):712-720.
    View in: PubMed
    Score: 0.013
  7. Editorial Comment on: Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses by Ayangbesan et al. (From: Ayangbesan A, Golombos DM, Golan R, et al. J Endourol 2019;33:50-60; DOI: 10.1089/end.2018.0144). J Endourol. 2019 01; 33(1):61.
    View in: PubMed
    Score: 0.013
  8. CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells. mBio. 2018 05 08; 9(3).
    View in: PubMed
    Score: 0.013
  9. Where there is smoke, there is not always fire. Cancer. 2018 06 01; 124(11):2276-2277.
    View in: PubMed
    Score: 0.013
  10. Editorial Comment. J Urol. 2018 01; 199(1):96.
    View in: PubMed
    Score: 0.012
  11. Neutral tumor evolution in myeloma is associated with poor prognosis. Blood. 2017 10 05; 130(14):1639-1643.
    View in: PubMed
    Score: 0.012
  12. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care. J Urol. 2016 12; 196(6):1640-1644.
    View in: PubMed
    Score: 0.011
  13. Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions. PLoS Pathog. 2016 Apr; 12(4):e1005564.
    View in: PubMed
    Score: 0.011
  14. Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma. Nat Commun. 2016 Jan 08; 7:10290.
    View in: PubMed
    Score: 0.011
  15. Surgical advances in bladder cancer: at what cost? Urol Clin North Am. 2015 May; 42(2):235-52, ix.
    View in: PubMed
    Score: 0.010
  16. Nutritional predictors of complications following radical cystectomy. World J Urol. 2015 Aug; 33(8):1129-37.
    View in: PubMed
    Score: 0.010
  17. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol. 2015 Jan; 193(1):30-5.
    View in: PubMed
    Score: 0.010
  18. Herpes simplex virus gE/gI extracellular domains promote axonal transport and spread from neurons to epithelial cells. J Virol. 2014 Oct; 88(19):11178-86.
    View in: PubMed
    Score: 0.010
  19. Editorial comment. Urology. 2014 Aug; 84(2):378-9.
    View in: PubMed
    Score: 0.010
  20. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity. BJU Int. 2014 Aug; 114(2):221-8.
    View in: PubMed
    Score: 0.010
  21. Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein. mBio. 2013 Jun 04; 4(3):e00332-13.
    View in: PubMed
    Score: 0.009
  22. Perioperative chemotherapy: when to use it, what to use, and why. Urol Clin North Am. 2013 May; 40(2):183-95.
    View in: PubMed
    Score: 0.009
  23. E2F1 and p53 transcription factors as accessory factors for nucleotide excision repair. Int J Mol Sci. 2012 Oct 19; 13(10):13554-68.
    View in: PubMed
    Score: 0.009
  24. PDGF receptor-a does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway. PLoS Pathog. 2012 Sep; 8(9):e1002905.
    View in: PubMed
    Score: 0.009
  25. The importance of entering cells, non-trivial solutions for serious viruses. Curr Opin Virol. 2012 Feb; 2(1):1-3.
    View in: PubMed
    Score: 0.008
  26. Human cytomegalovirus entry into cells. Curr Opin Virol. 2012 Feb; 2(1):37-42.
    View in: PubMed
    Score: 0.008
  27. Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J Virol. 2011 Nov; 85(22):11638-45.
    View in: PubMed
    Score: 0.008
  28. Accuracy of intra-articular glenohumeral injections: the anterosuperior technique with arthroscopic documentation. Arthroscopy. 2011 Jun; 27(6):745-9.
    View in: PubMed
    Score: 0.008
  29. Herpesviruses remodel host membranes for virus egress. Nat Rev Microbiol. 2011 May; 9(5):382-94.
    View in: PubMed
    Score: 0.008
  30. E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle. 2011 Apr 15; 10(8):1287-94.
    View in: PubMed
    Score: 0.008
  31. Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J Virol. 2011 Jun; 85(12):5919-28.
    View in: PubMed
    Score: 0.008
  32. Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma. J Clin Oncol. 2011 Mar 01; 29(7):797-804.
    View in: PubMed
    Score: 0.008
  33. A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J Virol. 2010 Mar; 84(5):2585-96.
    View in: PubMed
    Score: 0.007
  34. Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol. 2010 Mar; 84(5):2597-609.
    View in: PubMed
    Score: 0.007
  35. Fusion between perinuclear virions and the outer nuclear membrane requires the fusogenic activity of herpes simplex virus gB. J Virol. 2009 Nov; 83(22):11847-56.
    View in: PubMed
    Score: 0.007
  36. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol. 2009 Jul; 83(14):7285-95.
    View in: PubMed
    Score: 0.007
  37. Herpesvirus gB-induced fusion between the virion envelope and outer nuclear membrane during virus egress is regulated by the viral US3 kinase. J Virol. 2009 Apr; 83(7):3115-26.
    View in: PubMed
    Score: 0.007
  38. Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J Virol. 2008 Dec; 82(23):11837-50.
    View in: PubMed
    Score: 0.007
  39. Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood. 2008 Dec 15; 112(13):4924-34.
    View in: PubMed
    Score: 0.007
  40. HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A. 2008 Sep 16; 105(37):14118-23.
    View in: PubMed
    Score: 0.007
  41. Herpes simplex virus gE/gI and US9 proteins promote transport of both capsids and virion glycoproteins in neuronal axons. J Virol. 2008 Nov; 82(21):10613-24.
    View in: PubMed
    Score: 0.006
  42. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol. 2008 Jan; 82(1):60-70.
    View in: PubMed
    Score: 0.006
  43. Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane. Proc Natl Acad Sci U S A. 2007 Jun 12; 104(24):10187-92.
    View in: PubMed
    Score: 0.006
  44. A herpes simplex virus gD-YFP fusion glycoprotein is transported separately from viral capsids in neuronal axons. J Virol. 2007 Aug; 81(15):8337-40.
    View in: PubMed
    Score: 0.006
  45. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. Curr Mol Med. 2006 Nov; 6(7):739-48.
    View in: PubMed
    Score: 0.006
  46. Cytoplasmic residues of herpes simplex virus glycoprotein gE required for secondary envelopment and binding of tegument proteins VP22 and UL11 to gE and gD. J Virol. 2007 Jan; 81(1):319-31.
    View in: PubMed
    Score: 0.006
  47. Herpes simplex virus capsids are transported in neuronal axons without an envelope containing the viral glycoproteins. J Virol. 2006 Nov; 80(22):11165-77.
    View in: PubMed
    Score: 0.006
  48. The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins. J Biol Chem. 2006 Jul 28; 281(30):20910-20919.
    View in: PubMed
    Score: 0.006
  49. Herpes simplex virus gE/gI must accumulate in the trans-Golgi network at early times and then redistribute to cell junctions to promote cell-cell spread. J Virol. 2006 Apr; 80(7):3167-79.
    View in: PubMed
    Score: 0.005
  50. Silencing herpes simplex virus with a vaginal microbicide. N Engl J Med. 2006 Mar 02; 354(9):970-1.
    View in: PubMed
    Score: 0.005
  51. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proc Natl Acad Sci U S A. 2006 Jan 31; 103(5):1446-51.
    View in: PubMed
    Score: 0.005
  52. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol. 2006 Jan; 80(2):710-22.
    View in: PubMed
    Score: 0.005
  53. Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J Exp Med. 2005 Oct 17; 202(8):1109-19.
    View in: PubMed
    Score: 0.005
  54. The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors. J Virol. 2005 Sep; 79(18):11990-2001.
    View in: PubMed
    Score: 0.005
  55. A seek-and-hide game between Cd1-restricted T cells and herpesviruses. J Clin Invest. 2005 May; 115(5):1146-9.
    View in: PubMed
    Score: 0.005
  56. Redistribution of cellular and herpes simplex virus proteins from the trans-golgi network to cell junctions without enveloped capsids. J Virol. 2004 Nov; 78(21):11519-35.
    View in: PubMed
    Score: 0.005
  57. Impact of including drug spending in oncology alternative payment models. Am J Manag Care. 2023 11; 29(11):579-584.
    View in: PubMed
    Score: 0.005
  58. Potential Diagnostic Role for a Combined Postmortem DNA and RNA Sequencing for Brugada Syndrome. Circ Genom Precis Med. 2023 Dec; 16(6):e004251.
    View in: PubMed
    Score: 0.005
  59. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells. J Virol. 2003 Sep; 77(17):9287-94.
    View in: PubMed
    Score: 0.005
  60. Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm. J Virol. 2003 Aug; 77(15):8481-94.
    View in: PubMed
    Score: 0.005
  61. Viral inhibition of MHC class II antigen presentation. Trends Immunol. 2003 May; 24(5):278-85.
    View in: PubMed
    Score: 0.004
  62. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties. J Virol. 2003 Apr; 77(8):4731-8.
    View in: PubMed
    Score: 0.004
  63. Meniscal and Articular Cartilage Predictors of Outcome After Revision ACL Reconstruction: A 6-Year Follow-up Cohort Study. Am J Sports Med. 2023 03; 51(3):605-614.
    View in: PubMed
    Score: 0.004
  64. Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread. J Virol. 2003 Feb; 77(4):2686-95.
    View in: PubMed
    Score: 0.004
  65. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. J Virol. 2002 Aug; 76(16):8265-75.
    View in: PubMed
    Score: 0.004
  66. Descriptive Characteristics and Outcomes of Patients Undergoing Revision Anterior Cruciate Ligament Reconstruction With and Without Tunnel Bone Grafting. Am J Sports Med. 2022 07; 50(9):2397-2409.
    View in: PubMed
    Score: 0.004
  67. Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol. 2002 Jun; 76(11):5748-58.
    View in: PubMed
    Score: 0.004
  68. Returning to Activity After Anterior Cruciate Ligament Revision Surgery: An Analysis of the Multicenter Anterior Cruciate Ligament Revision Study (MARS) Cohort at 2 Years Postoperative. Am J Sports Med. 2022 06; 50(7):1788-1797.
    View in: PubMed
    Score: 0.004
  69. Identification of functionally important domains of human cytomegalovirus gO that act after trimer binding to receptors. PLoS Pathog. 2022 04; 18(4):e1010452.
    View in: PubMed
    Score: 0.004
  70. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol. 2002 Mar; 22(5):1360-8.
    View in: PubMed
    Score: 0.004
  71. Oncology alternative payment models: lessons from commercial insurance. Am J Manag Care. 2022 03; 28(3):98-100.
    View in: PubMed
    Score: 0.004
  72. Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands. Circ Genom Precis Med. 2021 10; 14(5):e003222.
    View in: PubMed
    Score: 0.004
  73. Association Between Graft Choice and 6-Year Outcomes of Revision Anterior Cruciate Ligament Reconstruction in the MARS Cohort. Am J Sports Med. 2021 08; 49(10):2589-2598.
    View in: PubMed
    Score: 0.004
  74. Prostate cancer. Nat Rev Dis Primers. 2021 02 04; 7(1):9.
    View in: PubMed
    Score: 0.004
  75. Rate of infection following revision anterior cruciate ligament reconstruction and associated patient- and surgeon-dependent risk factors: Retrospective results from MOON and MARS data collected from 2002 to 2011. J Orthop Res. 2021 02; 39(2):274-280.
    View in: PubMed
    Score: 0.004
  76. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings. J Urol. 2021 02; 205(2):444-451.
    View in: PubMed
    Score: 0.004
  77. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-na?ve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study. Eur Urol Oncol. 2022 10; 5(5):544-552.
    View in: PubMed
    Score: 0.004
  78. Meniscal Repair in the Setting of Revision Anterior Cruciate Ligament Reconstruction: Results From the MARS Cohort. Am J Sports Med. 2020 10; 48(12):2978-2985.
    View in: PubMed
    Score: 0.004
  79. Analysis of guideline recommended use of renal mass biopsy and association with treatment. Can J Urol. 2020 08; 27(4):10285-10293.
    View in: PubMed
    Score: 0.004
  80. Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients. Leukemia. 2020 11; 34(11):3091-3096.
    View in: PubMed
    Score: 0.004
  81. The paradox of E2F1: oncogene and tumor suppressor gene. Mol Carcinog. 2000 Mar; 27(3):151-7.
    View in: PubMed
    Score: 0.004
  82. The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy. World J Urol. 2020 Dec; 38(12):3113-3119.
    View in: PubMed
    Score: 0.004
  83. Longitudinal Associations Between Healthcare Resources, Policy, and Firearm-Related Suicide and Homicide from 2012 to 2016. J Gen Intern Med. 2020 07; 35(7):2043-2049.
    View in: PubMed
    Score: 0.004
  84. Using spatial tracking with magnetic resonance imaging/ultrasound-guided biopsy to identify unilateral prostate cancer. BJU Int. 2020 03; 125(3):399-406.
    View in: PubMed
    Score: 0.004
  85. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors. Urol Oncol. 2020 01; 38(1):1.e17-1.e23.
    View in: PubMed
    Score: 0.003
  86. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol. 1999 Sep; 19(9):6408-14.
    View in: PubMed
    Score: 0.003
  87. Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes. Hum Genomics. 2019 08 20; 13(1):37.
    View in: PubMed
    Score: 0.003
  88. Predictors of Patient-Reported Outcomes at 2 Years After Revision Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2019 08; 47(10):2394-2401.
    View in: PubMed
    Score: 0.003
  89. Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty. Urology. 2019 11; 133:25-33.
    View in: PubMed
    Score: 0.003
  90. Relationship Between Sports Participation After Revision Anterior Cruciate Ligament Reconstruction and 2-Year Patient-Reported Outcome Measures. Am J Sports Med. 2019 07; 47(9):2056-2066.
    View in: PubMed
    Score: 0.003
  91. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. Urol Oncol. 2019 09; 37(9):577.e9-577.e16.
    View in: PubMed
    Score: 0.003
  92. Regions of homozygosity as risk factors for multiple myeloma. Ann Hum Genet. 2019 07; 83(4):231-238.
    View in: PubMed
    Score: 0.003
  93. HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission. Proc Natl Acad Sci U S A. 2019 02 26; 116(9):3728-3733.
    View in: PubMed
    Score: 0.003
  94. The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation. Oncogene. 2019 04; 38(17):3216-3231.
    View in: PubMed
    Score: 0.003
  95. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999; 39:295-312.
    View in: PubMed
    Score: 0.003
  96. Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology. Blood Cancer J. 2018 12 21; 9(1):1.
    View in: PubMed
    Score: 0.003
  97. The genomic landscape of plasma cells in systemic light chain amyloidosis. Blood. 2018 12 27; 132(26):2775-2777.
    View in: PubMed
    Score: 0.003
  98. Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better? Urol Oncol. 2019 01; 37(1):63-70.
    View in: PubMed
    Score: 0.003
  99. Subclonal TP53 copy number is associated with prognosis in multiple myeloma. Blood. 2018 12 06; 132(23):2465-2469.
    View in: PubMed
    Score: 0.003
  100. The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes. J Virol. 2018 11 01; 92(21).
    View in: PubMed
    Score: 0.003
  101. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines. World J Urol. 2019 Jun; 37(6):1157-1164.
    View in: PubMed
    Score: 0.003
  102. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma. Urol Oncol. 2018 12; 36(12):527.e13-527.e19.
    View in: PubMed
    Score: 0.003
  103. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. Nat Commun. 2018 09 13; 9(1):3707.
    View in: PubMed
    Score: 0.003
  104. Differential activities of E2F family members: unique functions in regulating transcription. Mol Carcinog. 1998 Jul; 22(3):190-8.
    View in: PubMed
    Score: 0.003
  105. Physiologic Preoperative Knee Hyperextension Is a Predictor of Failure in an Anterior Cruciate Ligament Revision Cohort: A Report From the MARS Group. Am J Sports Med. 2018 10; 46(12):2836-2841.
    View in: PubMed
    Score: 0.003
  106. Role of E2F in cell cycle control and cancer. Front Biosci. 1998 Apr 27; 3:d447-8.
    View in: PubMed
    Score: 0.003
  107. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene. 1998 Mar 12; 16(10):1267-76.
    View in: PubMed
    Score: 0.003
  108. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol. 2018 Mar; 36(3):409-416.
    View in: PubMed
    Score: 0.003
  109. Risk Factors and Predictors of Significant Chondral Surface Change From Primary to Revision Anterior Cruciate Ligament Reconstruction: A MOON and MARS Cohort Study. Am J Sports Med. 2018 Mar; 46(3):557-564.
    View in: PubMed
    Score: 0.003
  110. Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma. Urol Oncol. 2018 02; 36(2):78.e21-78.e28.
    View in: PubMed
    Score: 0.003
  111. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. Urol Oncol. 2018 02; 36(2):79.e19-79.e26.
    View in: PubMed
    Score: 0.003
  112. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma. Urol Oncol. 2018 01; 36(1):9.e1-9.e9.
    View in: PubMed
    Score: 0.003
  113. High-affinity binding of the cell cycle-regulated transcription factors E2F1 and E2F4 to benzo[a]pyrene diol epoxide-DNA adducts. Mol Carcinog. 1997 Oct; 20(2):216-23.
    View in: PubMed
    Score: 0.003
  114. Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism. Cell Rep. 2017 Sep 12; 20(11):2556-2564.
    View in: PubMed
    Score: 0.003
  115. The Impact of Multiple Strategies to Encourage Fruit and Vegetable Consumption During School Lunch. J Sch Health. 2017 08; 87(8):616-622.
    View in: PubMed
    Score: 0.003
  116. Surgical Predictors of Clinical Outcomes After Revision Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2017 Sep; 45(11):2586-2594.
    View in: PubMed
    Score: 0.003
  117. Search for rare protein altering variants influencing susceptibility to multiple myeloma. Oncotarget. 2017 May 30; 8(22):36203-36210.
    View in: PubMed
    Score: 0.003
  118. Subsequent Surgery After Revision Anterior Cruciate Ligament Reconstruction: Rates and Risk Factors From a Multicenter Cohort. Am J Sports Med. 2017 Jul; 45(9):2068-2076.
    View in: PubMed
    Score: 0.003
  119. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials. J Urol. 2018 01; 199(1):43-52.
    View in: PubMed
    Score: 0.003
  120. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. Sci Rep. 2017 01 23; 7:41071.
    View in: PubMed
    Score: 0.003
  121. Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral Center. Urology. 2017 04; 102:31-37.
    View in: PubMed
    Score: 0.003
  122. Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression. Nat Commun. 2016 11 24; 7:13656.
    View in: PubMed
    Score: 0.003
  123. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. Nat Commun. 2016 07 01; 7:12050.
    View in: PubMed
    Score: 0.003
  124. The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. Clin Cancer Res. 2016 Dec 01; 22(23):5783-5794.
    View in: PubMed
    Score: 0.003
  125. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. J Clin Oncol. 2015 Nov 20; 33(33):3911-20.
    View in: PubMed
    Score: 0.003
  126. Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma. Sci Rep. 2015 Jul 24; 5:12473.
    View in: PubMed
    Score: 0.003
  127. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015 Apr 23; 6:6997.
    View in: PubMed
    Score: 0.003
  128. FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun. 2015 Mar 03; 6:6395.
    View in: PubMed
    Score: 0.003
  129. Improving couples' quality of life through a Web-based prostate cancer education intervention Oncol Nurs Forum. 2015 03; 42(2):183-92.
    View in: PubMed
    Score: 0.003
  130. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells. Haematologica. 2015 Mar; 100(3):e110-3.
    View in: PubMed
    Score: 0.003
  131. A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue. Leuk Lymphoma. 2015 Mar; 56(3):594-601.
    View in: PubMed
    Score: 0.002
  132. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 1994 Jul 01; 8(13):1514-25.
    View in: PubMed
    Score: 0.002
  133. Human cytomegalovirus Fc? binding proteins gp34 and gp68 antagonize Fc? receptors I, II and III. PLoS Pathog. 2014 May; 10(5):e1004131.
    View in: PubMed
    Score: 0.002
  134. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance. Blood. 2014 Apr 17; 123(16):2513-7; quiz 2593.
    View in: PubMed
    Score: 0.002
  135. Identification of prohibitin and prohibiton as novel factors binding to the p53 induced gene 3 (PIG3) promoter (TGYCC)(15) motif. Biochem Biophys Res Commun. 2014 Jan 24; 443(4):1239-44.
    View in: PubMed
    Score: 0.002
  136. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet. 2013 Oct; 45(10):1221-1225.
    View in: PubMed
    Score: 0.002
  137. Bringing bike share to a low-income community: lessons learned through community engagement, Minneapolis, Minnesota, 2011. Prev Chronic Dis. 2013 Aug 15; 10:E138.
    View in: PubMed
    Score: 0.002
  138. Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia. 2014 Feb; 28(2):384-390.
    View in: PubMed
    Score: 0.002
  139. Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol. 2013 Aug; 162(3):348-59.
    View in: PubMed
    Score: 0.002
  140. Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood. 2013 Jul 11; 122(2):219-26.
    View in: PubMed
    Score: 0.002
  141. The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat Genet. 2013 May; 45(5):522-525.
    View in: PubMed
    Score: 0.002
  142. Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells. Blood. 2013 Apr 25; 121(17):3413-9.
    View in: PubMed
    Score: 0.002
  143. Altered fear learning across development in both mouse and human. Proc Natl Acad Sci U S A. 2012 Oct 02; 109(40):16318-23.
    View in: PubMed
    Score: 0.002
  144. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood. 2012 Aug 02; 120(5):1077-86.
    View in: PubMed
    Score: 0.002
  145. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet. 2011 Nov 27; 44(1):58-61.
    View in: PubMed
    Score: 0.002
  146. Repression of androgen receptor transcription through the E2F1/DNMT1 axis. PLoS One. 2011; 6(9):e25187.
    View in: PubMed
    Score: 0.002
  147. Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients. Haematologica. 2011 Nov; 96(11):1728-32.
    View in: PubMed
    Score: 0.002
  148. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck. Mol Carcinog. 2011 Sep; 50(9):697-706.
    View in: PubMed
    Score: 0.002
  149. Regulation of cellular invasion and matrix metalloproteinase activity in HepG2 cell by connexin 26 transfection. Mol Carcinog. 2001 Jun; 31(2):101-9.
    View in: PubMed
    Score: 0.002
  150. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol. 2011 Jul; 128(1):242-246.e5.
    View in: PubMed
    Score: 0.002
  151. Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells. Vaccine. 2011 Mar 24; 29(15):2705-11.
    View in: PubMed
    Score: 0.002
  152. A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell. 2010 Sep 14; 18(3):220-30.
    View in: PubMed
    Score: 0.002
  153. The RB-E2F1 pathway regulates autophagy. Cancer Res. 2010 Oct 15; 70(20):7882-93.
    View in: PubMed
    Score: 0.002
  154. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood. 2010 Oct 14; 116(15):e56-65.
    View in: PubMed
    Score: 0.002
  155. XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood. 2010 Jul 15; 116(2):250-3.
    View in: PubMed
    Score: 0.002
  156. Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res. 2010 Mar 15; 16(6):1856-64.
    View in: PubMed
    Score: 0.002
  157. The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes. Mol Cell Biol. 1990 Mar; 10(3):982-90.
    View in: PubMed
    Score: 0.002
  158. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature. 2010 Jan 07; 463(7277):49-53.
    View in: PubMed
    Score: 0.002
  159. Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res. 2008 Oct 01; 14(19):6033-41.
    View in: PubMed
    Score: 0.002
  160. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res. 2007 Aug 01; 67(15):7212-22.
    View in: PubMed
    Score: 0.002
  161. Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma. Blood. 2007 Nov 01; 110(9):3291-300.
    View in: PubMed
    Score: 0.001
  162. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9.
    View in: PubMed
    Score: 0.001
  163. Clinical crown length of the maxillary anterior teeth preorthodontics and postorthodontics. J Periodontol. 2007 Apr; 78(4):645-53.
    View in: PubMed
    Score: 0.001
  164. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood. 2006 Sep 01; 108(5):1733-43.
    View in: PubMed
    Score: 0.001
  165. Inhibition of TCR signaling by herpes simplex virus. J Immunol. 2006 Feb 01; 176(3):1825-33.
    View in: PubMed
    Score: 0.001
  166. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
    View in: PubMed
    Score: 0.001
  167. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol Cell Biol. 2004 Sep; 24(17):7538-47.
    View in: PubMed
    Score: 0.001
  168. Hyperconcavity of the lumbar vertebral endplates in the elite football lineman. Am J Sports Med. 2004 Sep; 32(6):1434-9.
    View in: PubMed
    Score: 0.001
  169. Silica and noise exposure during installation of fibercement siding. J Occup Environ Hyg. 2004 Jan; 1(1):D1-6.
    View in: PubMed
    Score: 0.001
  170. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med. 2003 Jun 02; 197(11):1427-39.
    View in: PubMed
    Score: 0.001
  171. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res. 2000 Nov 01; 60(21):5972-6.
    View in: PubMed
    Score: 0.001
  172. Rapid analysis of gene expression (RAGE) facilitates universal expression profiling. Nucleic Acids Res. 1999 Dec 01; 27(23):4609-18.
    View in: PubMed
    Score: 0.001
  173. Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene. Oncogene. 1999 Nov 04; 18(46):6343-56.
    View in: PubMed
    Score: 0.001
  174. Disruption of transcription in vitro and gene expression in vivo by DNA adducts derived from a benzo[a]pyrene diol epoxide located in heterologous sequences. Carcinogenesis. 1997 Feb; 18(2):239-44.
    View in: PubMed
    Score: 0.001
  175. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol Cell Biol. 1993 Oct; 13(10):6314-25.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.